Search results
Results From The WOW.Com Content Network
Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...
The following are list of bioCSL flu vaccine brands: [31] Trivalent. Afluria, also marketed as Enzira, Fluvax, and Nilgrip in various different markets. Agrippal, also marketed as Begripal, Fluazur, Sandovac, Agriflu, and Chiroflu in various different markets. Fluad, [32] [1] also marketed as Chiromas in Spain.
United States. Anti-Vaccination League of America. Anti-Vaccination Society of America. Association of American Physicians and Surgeons. The Autism Community in Action (TACA; formerly Talk About Curing Autism) Children's Health Defense. Children's Medical Safety Research Institute. Freedom Angels Foundation. Health Freedom Idaho.
RA638 .L37 2020. Stuck: How Vaccine Rumors Start and Why They Don't Go Away (2020), published by Oxford University Press and written by the director of the London School of Hygiene and Tropical Medicine 's Vaccine Confidence Project, Heidi Larson, looks at what influences attitudes to vaccination. It was largely compiled before the COVID-19 ...
The anti-vax campaign is the latest in a series of pro-American disinformation campaigns that have been exposed over the past few years. While the U.S. government warns about the use of "fake or ...
This is a timeline of the development of prophylactic human vaccines. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became available on the market. Although vaccines exist for the diseases listed below, only smallpox has been eliminated worldwide ...
Novavax, Inc. Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases.
Novartis made use of the EMR to obtain orders against some generic manufacturers who had already launched Gleevec in India. When examination of Novartis' patent application began in 2005, it came under immediate attack from oppositions initiated by generic companies that were already selling Gleevec in India and by advocacy groups. The ...